An experimental drug lecanemab slows down cognitive decline in Alzheimer’s patients

An experimental drug, lecanemab, slows down cognitive decline in Alzheimer’s patients

After a clinical trial showed that it reduces the progression of cognitive deterioration in people with early stages of the…

Read More »